Clinical trial
Evaluating the Prescribing Pattern and Knowledge, Attitude and Practice as Well as the Adherence Level to Iron Chelation Therapy in Thalassemia
NCT06210139 is registered in ClinicalTrials.gov with Reem Ali Shaker as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Prescribing Pattern and Knowledge, Attitude and Practice as Well as the Adherence Level to Iron Chelation Therapy in Thalassemia
- Lead sponsor
- Reem Ali Shaker
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 28, 2023
- Completion date
- February 28, 2024
- Enrollment
- 199 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.